ARMISTICE CAPITAL, LLC
SEC Form 13F institutional filer · CIK 0001601086
13F-HR · 62 reported holdings · 2026-03-31
Armistice Capital, LLC is a hedge fund.
Reported long-US-equity value
$0.71B
Top-10 concentration
53.4%
ARMISTICE CAPITAL, LLC — $705M AUM allocation strategy
ARMISTICE CAPITAL, LLC files SEC Form 13F and reports $705M of long US equity value across 62 reported holdings for 2026-03-31.
Its largest sector bet is Health Care 41.3%, followed by Consumer Discretionary 14.2% and Information Technology 7.9%.
The top 10 holdings account for 53% of reported value — a conviction-weighted book concentrated in its best ideas. The sector and industry splits below are of the same reported value. Track quarter-over-quarter adds, trims, new positions and exits below — sourced from SEC 13F filings, public domain.
ARMISTICE CAPITAL, LLC — latest SEC 13F insights
Reported long-US-equity value (13F AUM)
$705M
total across 62 reported holdings · 2026-03-31 · excludes shorts, cash, non-US
Top-10 concentration
53% of value
higher = narrower conviction; lower = spread / hedging
Biggest adds (shares)
+$UBER +236K sh · +$14.2M+$INTC +101K sh · +$5.35M+$ALGN +81.9K sh · +$15.2M
Biggest trims (shares)
−$KVUE −3.96M sh · −$68.4M−$GEHC −674K sh · −$56.5M−$INCY −441K sh · −$46.6M
Exited to nil (held last quarter, gone now)
$SBUX ($46.3M last qtr)$MDT ($26.1M last qtr)$DHR ($24.5M last qtr)$CVS ($23.5M last qtr)$DXCM ($21.4M last qtr)
Sector allocation (share of reported value)
each slice is a share of the reported long-US-equity value — smaller sectors and the rest of the book roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Industry allocation (share of reported value)
- Biotechnology12.7%—
- Managed Health Care9.1%—
- Life Sciences Tools & Services7.8%—
- Broadline Retail7.8%—
- Interactive Media & Services7.5%—
- Health Care Equipment5.9%—
- Passenger Ground Transportation5.3%—
- Health Care Supplies3.8%—
- Other holdings40.1%—
the finer GICS cut of the same book — same denominator — smaller industries roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Top S&P 500 holdings
10 of 10 rows · sorted by Value ↓
| Ticker | Holding | Shares | Value | Δ QoQ | Weight |
|---|---|---|---|---|---|
| $INCY | Incyte Corp | 657K | $61.8M | -441K | 8.8% |
| $AMZN | Amazon.com Inc | 262K | $54.6M | -105K | 7.7% |
| $TMO | Thermo Fisher Scientific Inc | 91.5K | $45M | +28.7K | 6.4% |
| $UNH | UnitedHealth Group Incorporated | 148K | $40M | — | 5.7% |
| $UBER | Uber Technologies Inc | 519K | $37.3M | +236K | 5.3% |
| $GOOG | Alphabet Inc. Class C Capital Stock | 119K | $34.1M | -77.9K | 4.8% |
| $REGN | Regeneron Pharmaceuticals Inc | 36.1K | $27.9M | -47.9K | 4.0% |
| $ALGN | Align Technology Inc | 158K | $27.1M | +81.9K | 3.8% |
| $DDOG | Datadog Inc | 209K | $24.6M | -36K | 3.5% |
| $HUM | Humana Inc | 141K | $24.5M | +69.6K | 3.5% |
…and 52 more holdings in the full 13F filing (top positions only shown).
SEC Form 13F data sets · public domain · 45-day filing lag · >$100M AUM managers · as reported
← All 13F filers·← QuantOrb.pro
How to read Δ QoQ — the five insight categories, and the caveats
The categories. Analysts, quants and retail traders look past total portfolio value to isolate actionable signals. Five categories matter.
Conviction & concentration shifts
New positions vs complete exits — a brand-new stock signals high conviction; a full liquidation suggests a broken thesis or tax-loss harvesting. Aggressive sizing — look at share count, not dollars: a 20% share increase during a drawdown is strong dip-buying. Concentration — a narrowing top-5/10 means conviction; spreading capital across more names means hedging.
Sector & macro allocation rotations
Aggregating Δ QoQ moves across sectors shows where smart money is leaning in or sneaking out — rotating out of growth into defensives or energy, for example. The fund's total long equity exposure quarter-over-quarter is a proxy for overall institutional risk appetite.
Crowding & smart-money consensus
When several managers initiate or expand the same stock in the same quarter, that is institutional consensus. Contrarian reads: top pickers buying hard into a beaten-down name the market is selling.
Derivative & option overlays
Reported call/put changes indicate whether managers are adding downside hedges or leveraging upside exposure. Note: a long increase may be half of a market-neutral pair trade.
Who reads this
| Retail "cloners" | High-conviction ideas to replicate ~45 days after quarter-end. |
| Corporate IR | Which funds bought or dumped the stock, before the next call. |
| Quant / algo traders | Cross-sectional factor inputs: flow, momentum, ownership. |
Four caveats before you trade on it
- 45-day lag — holdings are quarter-end; positions may already be closed.
- Long-only — 13Fs miss shorts, pair trades and cash.
- No non-US / fixed income — the picture is US equities plus options.
- Corporate actions — splits and spinoffs distort raw share deltas.
Newsletter signup
Free subscription. Daily trading day morning dispatch. No spam.